ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Breast cancer session was ASCO equivalent of a rock concert, discussant says.

May 27, 2005

Draft of National Action Plan On Breast Cancer Targets Health Care, Research, Policy

March 23, 1994

In Brief: James Wallace Named CALGB Executive Officer; Gritz Receives First Joseph Cullen Award

September 11, 1992

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976